Osaic Holdings
ORGO icon

Osaic Holdings’s Organogenesis Holdings ORGO Stock Holding History

Osaic Holdings’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6K Buy
7,655
+127
+2% +$310 ﹤0.01% 6228
2026
Q1 		$17.8K Sell
7,528
-1,972
-21% -$6.83K ﹤0.01% 5926
2025
Q4 		$49.2K Hold
9,500
– – ﹤0.01% 5244
2025
Q3 		$40.5K Sell
9,500
-1
-0% -$5 ﹤0.01% 5453
2025
Q2 		$34.8K Buy
9,501
+101
+1% +$376 ﹤0.01% 5303
2025
Q1 		$40.6K Sell
9,400
-300
-3% -$1.21K ﹤0.01% 4867
2024
Q4 		$31K Sell
9,700
-4,636
-32% -$15.6K ﹤0.01% 5047
2024
Q3 		$41K Sell
14,336
-500
-3% -$1.4K ﹤0.01% 4885
2024
Q2 		$41.5K Sell
14,836
-212
-1% -$569 ﹤0.01% 4819
2024
Q1 		$42.7K Buy
15,048
+1,286
+9% +$4.37K ﹤0.01% 4860
2023
Q4 		$56.3K Buy
13,762
+601
+5% +$1.68K ﹤0.01% 4835
2023
Q3 		$41.9K Buy
13,161
+2,725
+26% +$8.66K ﹤0.01% 5109
2023
Q2 		$34.6K Buy
10,436
+200
+2% +$591 ﹤0.01% 5189
2023
Q1 		$21.8K Hold
10,236
– – ﹤0.01% 5534
2022
Q4 		$28K Sell
10,236
-800
-7% -$2.33K ﹤0.01% 5339
2022
Q3 		$36K Buy
11,036
+6,546
+146% +$29.6K ﹤0.01% 5151
2022
Q2 		$22K Sell
4,490
-646
-13% -$3.98K ﹤0.01% 5550
2022
Q1 		$39K Sell
5,136
-1,053
-17% -$8.15K ﹤0.01% 5268
2021
Q4 		$57K Buy
6,189
+1,277
+26% +$13.6K ﹤0.01% 5047
2021
Q3 		$70K Buy
4,912
+282
+6% +$4.38K ﹤0.01% 4838
2021
Q2 		$78K Buy
4,630
+924
+25% +$17.2K ﹤0.01% 4689
2021
Q1 		$67K Sell
3,706
-100
-3% -$1.35K ﹤0.01% 4663
2020
Q4 		$29K Buy
3,806
+100
+3% +$475 ﹤0.01% 4936
2020
Q3 		$14K Sell
3,706
-789
-18% -$3.12K ﹤0.01% 5110
2020
Q2 		$17K Buy
4,495
+789
+21% +$2.85K ﹤0.01% 4895
2020
Q1 		$12K Buy
+3,706
New +$15.9K ﹤0.01% 4909

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Osaic Holdings's ORGO Position: Q2 2026 in Review

Osaic Holdings increased its Organogenesis Holdings (ORGO) stake by 1.7% in Q2 2026, buying an estimated $310 and bringing the position to 7,655 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6228.

Osaic Holdings first reported a position in ORGO in Q1 2020 and has held it in 26 quarters since. The position peaked at $78K in Q2 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Osaic Holdings held 7,655 shares of Organogenesis Holdings worth $18.6K as of Q2 2026.
  • Osaic Holdings bought 127 Organogenesis Holdings shares in Q2 2026, an estimated $310.
  • Organogenesis Holdings made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6228 holding.
  • Osaic Holdings first reported a position in Organogenesis Holdings in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Organogenesis Holdings position peaked at $78K in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.